Considering the favorable effects of bile acid receptors FXR and TGR5 on obesity, exploration of FXR and TGR5 agonists holds promise as a novel avenue for research in obesity treatment. Here, NR1H4 is linked to obesity due to melanocortin 4 receptor deficiency.